Search
for
Sort by
Research 721–750 of 1000+
- Association between alopecia areata and COVID-19: A systematic review
- What is behind the ‘swarm of bees’ in alopecia areata
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Development and validation of the Brigham Eyelash Tool for Alopecia (BELA): A measure of eyelash alopecia areata
- Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- The causal relationship between gut microbiota and alopecia areata: a Mendelian randomization analysis
- Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review
- Health‐related quality of life of adult and adolescent patients living with alopecia areata in Australia
- Is the severity of alopecia areata associated with arterial stiffness?
- Associations between season, climate, and pediatric alopecia areata flares in Providence, Rhode Island
- Anxiety and Depression in Patients with Alopecia Areata in Eskisehir, Turkey
- Quality of Life and Mood Status Disturbances in Cohabitants of Patients with Alopecia Areata: A Cross-Sectional Study in a Spanish Population
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Clinical Presentations and Comorbidities of Pediatric Alopecia Areata
- Clinical and pathological evaluation of hemp seeds oil effectiveness in the treatment of alopecia areata
- The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata
- The effects of garlic topical gel (5%) in the treatment of alopecia areata
- A novel predictive model for the recurrence of pediatric alopecia areata by bioinformatics analysis and a single-center prospective study
- Evaluation of platelet-rich plasma in treatment of alopecia areata
- Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate (DHEA-S) in the majority of the alopecia areata patients: Is it a primitive and pathogenic perturbation of hypothalamic-pituitary-adrenal axis?
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Efficacy and safety of compound glycyrrhizin combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized controlled trials
- A Novel Fusion Technique for Early Detection of Alopecia Areata Using ResNet-50 and CRSHOG
- Alopecia areata: trichoscopic markers in determining disease activity
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Efficacy of topical tacrolimus 0.1% and clobetasol propionate 0.05% in the treatment of alopecia areata
- Why steroids may not always work in alopecia areata: elevated unoccupied glucocorticoid receptors and decreased levels of thioredoxin
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3